Stock Events

Stock Events

Bristol-Myers Squibb 

$0.105000
8941
-$0.00-4.46% 17:55 Today

Statistics

Day High
0.1101
Day Low
0.105
52W High
0.1101
52W Low
0.105
Volume
4,284
Avg. Volume
-
Mkt Cap
214.49M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

29OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
1.09
1.41
1.72
2.04
Expected EPS
1.723538
Actual EPS
N/A

Financials

14.64%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
48.19BRevenue
7.05BNet Income

Analyst Ratings

68.36Average Price Target
The highest estimate is 75.00.
From 11 ratings within the last 6 months. This is not an investment recommendation.
Buy
55%
Hold
45%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CELG-RI. It's not an investment recommendation.
Realty Income
2361
O
Coca-Cola
1986
KO
Apple
1985
AAPL
Johnson & Johnson
1947
JNJ

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap152.69B
Pfizer competes directly in various therapeutic areas including oncology, immunology, and cardiovascular diseases.
Merck
MRK
Mkt Cap335.14B
Merck & Co. is a key competitor in the pharmaceutical industry, especially in the oncology segment with its blockbuster cancer drug Keytruda.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson competes across multiple segments including pharmaceuticals, with a strong presence in immunology and oncology.
Abbvie
ABBV
Mkt Cap440.83B
AbbVie competes in areas like immunology and oncology, directly challenging Bristol-Myers Squibb's product lineup.
GSK
GSK
Mkt Cap99.18B
GlaxoSmithKline competes in the pharmaceutical and healthcare sector, with a focus on respiratory diseases, HIV, and vaccines.
Novartis
NVS
Mkt Cap286.78B
Novartis is a global healthcare company that competes in various therapeutic areas including cardiovascular, oncology, and immunology.
AMGEN
AMGN
Mkt Cap224.63B
Amgen competes in the biopharmaceutical sector, focusing on human therapeutics, including treatments for cancer and cardiovascular disease.
Sanofi
SNY
Mkt Cap104.76B
Sanofi competes in the global pharmaceutical market, with a focus on diabetes, oncology, and rare diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, with a strong emphasis on oncology and immunology.
Astrazeneca
AZN
Mkt Cap242.64B
AstraZeneca is a global, science-led biopharmaceutical business that competes in core areas of healthcare, including oncology, cardiovascular, renal, and metabolism.

About

Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
Show more...
CEO
Christopher S. Boerner
Employees
32500
Country
United States
ISIN
US1101221406

Listings

STU
DE
BRM.STU
XETRA
DE
BRM.XETRA
BA
AR
BMY.BA
SA
BR
BMYB34.SA

0 Comments

Share your thoughts

FAQ

What is Bristol-Myers Squibb stock price today?▼
The current price of CELG-RI is $0.11 USD — it has decreased by -4.46% in the past 24 hours. Watch Bristol-Myers Squibb stock price performance more closely on the chart.
What is Bristol-Myers Squibb stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Bristol-Myers Squibb stocks are traded under the ticker CELG-RI.
What is Bristol-Myers Squibb market cap?▼
Today Bristol-Myers Squibb has the market capitalization of 214.49M
When is the next Bristol-Myers Squibb earnings date?▼
Bristol-Myers Squibb is going to release the next earnings report on October 29, 2026.
What were Bristol-Myers Squibb earnings last quarter?▼
CELG-RI earnings for the last quarter are 2.04 USD per share, whereas the estimation was 1.6 USD resulting in a +27.73% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Bristol-Myers Squibb revenue for the last year?▼
Bristol-Myers Squibb revenue for the last year amounts to 48.19B USD.
What is Bristol-Myers Squibb net income for the last year?▼
CELG-RI net income for the last year is 7.05B USD.
How many employees does Bristol-Myers Squibb have?▼
As of August 19, 2026, the company has 32,500 employees.
In which sector is Bristol-Myers Squibb located?▼
Bristol-Myers Squibb operates in the Health & Wellness sector.
When did Bristol-Myers Squibb complete a stock split?▼
Bristol-Myers Squibb has not had any recent stock splits.
Where is Bristol-Myers Squibb headquartered?▼
Bristol-Myers Squibb is headquartered in PRINCETON, United States.